The purpose of this study was to investigate if enalapril could be adm
inistered with cyclosporin A (CyA) to reduce its nephrotoxicity. Sixty
rats were divided into five groups: group I, Control group; group II,
rats treated with oral enalapril; group III, rats treated with CyA; g
roup IV, rats treated with CyA and enalapril; group V, rats treated wi
th enalapril before the CYA therapy. At the end of the therapy mean se
rum creatinine concentrations were not statistically different between
the groups (P>0.05), in groups treated with CyA there were no statist
ically significant differences between mean CyA levels (P>0.05), and m
ean blood urea nitrogen levels of the groups treated with CYA were sig
nificantly elevated (P<0.05) compared with groups not treated with CyA
. Morphologically acute CyA nephrotoxicity was evaluated by the follow
ing features: (1) tubular vacuolization, (2) tubular necrosis, (3) tub
ular microcalcification, and (4) peritubular capillary congestion. The
se lesions were scored semiquantitatively on a scale from 0 to 4+. The
most common tubular pathology was tubular vacuolization, which was mo
re severe in groups III and IV. Tubular necrosis was most severe in gr
oup III. In conclusion, enalapril seems to suppress the severest form
of CyA nephrotoxicity, namely tubular necrosis, if administered prior
to CyA treatment.